SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease
ContributorsRamirez, Alfredo; van der Flier, Wiesje M; Herold, Christine; Ramonet, David
CollaboratorsPopp, Julius
Published inHuman Molecular Genetics, vol. 23, no. 24, p. 6644-6658
Publication date2014
Abstract
Keywords
- Aged
- Alzheimer Disease/cerebrospinal fluid/genetics/pathology
- Amyloid beta-Peptides/cerebrospinal fluid/genetics
- Apolipoprotein E4/cerebrospinal fluid/genetics
- Cognition
- Female
- Gene Expression Regulation
- Genome-Wide Association Study
- Humans
- Male
- Nuclear Proteins/cerebrospinal fluid/genetics
- Peptide Fragments/cerebrospinal fluid/genetics
- Phosphorylation
- Polymorphism
- Single Nucleotide
- RNA-Binding Proteins/cerebrospinal fluid/genetics
- Serine-Arginine Splicing Factors
- Signal Transduction
- tau Proteins/cerebrospinal fluid/genetics
Affiliation entities Not a UNIGE publication
Citation (ISO format)
RAMIREZ, Alfredo et al. SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer’s disease. In: Human Molecular Genetics, 2014, vol. 23, n° 24, p. 6644–6658. doi: 10.1093/hmg/ddu372
Main files (1)
Article (Published version)
Identifiers
- PID : unige:106698
- DOI : 10.1093/hmg/ddu372
- PMID : 25027320
Journal ISSN0964-6906